| Literature DB >> 36005515 |
Mingxing Qi1, Caijuan Zheng2,3, Wenhui Wu1, Guangli Yu4,5, Peipei Wang1.
Abstract
The unique living environment of marine microorganisms endows them with the potential to produce novel chemical compounds with various biological activities. Among them, the exopolysaccharides produced by marine microbes are an important factor for them to survive in these extreme environments. Up to now, exopolysaccharides from marine microbes, especially from extremophiles, have attracted more and more attention due to their structural complexity, biodegradability, biological activities, and biocompatibility. With the development of culture and separation methods, an increasing number of novel exopolysaccharides are being found and investigated. Here, the source, structure and biological activities of exopolysaccharides, as well as their potential applications in environmental restoration fields of the last decade are summarized, indicating the commercial potential of these versatile EPS in different areas, such as food, cosmetic, and biomedical industries, and also in environmental remediation.Entities:
Keywords: biological activities; environmental remediation; exopolysaccharides; marine microorganisms; structure
Mesh:
Substances:
Year: 2022 PMID: 36005515 PMCID: PMC9409974 DOI: 10.3390/md20080512
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Information of some EPS obtained from marine bacteria in the last decade.
| Source | Name | Preparation Method | Monosaccharides | Mw (Da) | Bioactivity | References |
|---|---|---|---|---|---|---|
| EPS-S3 | Ethanol precipitation extraction and purification by | Glc, Gal, GalNAc, GalN | 1.75 × 105 | Promotion of Wound Healing | [ | |
|
| EPS-M41 | Culture centrifugal extraction and purification by ultra-filtration | Ara, Man, Glc, Gal | 6.8 × 105 | Antioxidant, | [ |
|
| EPS | Culture centrifugal extraction and purification by dialysis | Man, Glc, Xyl, Rha | Waste-water | [ | |
|
| EPS | Ethanol precipitation and | Man, Glc, Ara | 2.14 × 106 | Anti-biofilm | [ |
| EPS | Culture centrifugal extraction and purification by Sepharose 4-LB Fast Flow column | Fuc, Gal, Xyl, Glc, Rha, Man | Antioxidant, | [ | ||
|
| EPS | Culture centrifugal extraction and purification by ultra-filtration | GalA, GlcA, Rha, GlcN | >1.0 × 106 | [ | |
| EPS5SH | Aqueous extraction and purification by GPC | Man, GlcN, Glc, Gal | 8.9 × 104 | Immunomodulatory activity | [ | |
| EPS | Ethanol precipitation extraction and purification by DEAE column | GalA, Man, Rha | >1.67 × 105 | [ | ||
| EPS-DR3A | Culture centrifugal extraction and purification by dialysis | Fuc, Erythrotetrose, Glc, Rib | 2 × 104 | Antioxidant | [ | |
| EPS | Culture centrifugal extraction | Glc, Gal, Fuc, GlcA | Antibacterial | [ | ||
| EPS273 | Culture centrifugal extraction and purification by GPC | GlcN, Rha, Glc | 1.9 × 105 | Antibiofilm, | [ | |
| EPS Mi25 | Culture centrifugal extraction and purification by dialysis | Glc, Man, Fuc, GlcA | 7.0 × 106 | Antioxidant | [ | |
|
| EPSR3 | Culture centrifugal extraction | Glc, GalA, Arb | Antioxidant, | [ | |
| A101 | Ethanol precipitation extraction and purification by GPC | GlcA, GalA, Rha, GlcN | 5.46 × 103 | Antibacterial | [ | |
|
| EPS | Culture centrifugal extraction and purification by Sepharose 4-LB Fast Flow column | Gal, Glc | Antioxidant | [ | |
| hsEPS | Ethanol precipitation, anion-exchange and gel-filtration chromatography | Man, Glc, Ara, Xyl, Gal, Fuc | 5.133 × 104 | Emulsifying activity | [ | |
|
| EPS | Culture centrifugal extraction and purification by QFF | QuiN, GalA | Antifreeze | [ | |
|
| SM20310 | Ethanol precipitation | Rha, Xyl, Man, Gal, Glc, GalNAc, GlcNAc | >2.0 × 106 | Anti-freeze | [ |
| EPS2E1 | Culture centrifugal extraction and purification by DEAE column and Sephadex G75 column | Man, Glc | 4.7 × 104 | Immunomodulatory activity | [ | |
| Sphingobatan | Culture centrifugal extraction and purification by DEAE column | Man | >2 × 106 | Immunomodulatory activity | [ | |
| PEP | Culture centrifugal extraction and purification by dialysis and GPC | Glc, Gal, Man | 3.97 × 105 | Anticancer | [ | |
| SM1127 EPS | Ethanol precipitation extraction and purification by Sepharose column | Rha, Fuc, GlcA, Man, Gal, Glc, GlcNAc | 2.2 × 105 | Promotion of Wound Healing, Prevention | [ | |
|
| EPS1, | Culture centrifugal extraction and purification by Sepharose DEAE CL-6B column | Man, Glc, GalN, GlcN, Gal, Rib | 7 × 105; | [ | |
|
| EPS RH-7 | Ethanol precipitation and purification by dialysis | Glc, GlcA, Rha, Gal | 2 × 106 | Emulsifying | [ |
|
| GY785 | Culture centrifugal extraction and purification by | Rha, Fuc, Man, Gal, Glc, GalA, GlcA | 2.0 × 106 | [ |
Information of some EPS obtained from marine fungi in the last decade.
| Source | Name | Preparation Method | Monosaccharides | Mw (Da) | Bioactivity | References |
|---|---|---|---|---|---|---|
| AUM-1 | Alcohol precipitation and further purified through DEAE-column | Glc, Man, Gal | 6.0 × 103 | Immunomodulatory activity | [ | |
|
| YSS | Culture centrifugal extraction and purification by QFF column | Glc, Man | 1.86 × 104 | Antioxidant | [ |
|
| Fw-1 | Culture centrifugal extraction and purification by QFF column | Gal, Glc, Man | 6.12 × 104 | Antioxidant | [ |
| AS2-1 | Culture centrifugal extraction and purification by QFF column | Man, Glc, Gal | 2.74 × 104 | Anticancer, | [ | |
|
| AWP | Culture centrifugal extractionand purification by QFF column | Glc, Man | 5 × 107 | [ | |
|
| LCJ-5-4 | Culture centrifugal extractionand purification by QFF column | Glc, Man | 7 × 103 | Antioxidant | [ |
|
| GW-12 | Ethanol precipitation, | Man | 1.13 × 104 | [ | |
|
| HPA | Ethanol precipitation, | Man, Gal, Glc, | 2.25 × 104 | Anticancer | [ |
Information of some EPS obtained from marine microalgae and cyanobacteria in the last decade.
| Source | Name | Preparation Method | Monosaccharides Composition | Mw (Da) | Bioactivity | References |
|---|---|---|---|---|---|---|
|
| EPS | Cold aqueous centrifugal | Fuc, Rha, Ara, Gal, Glc, Xyl, GlcA (1.93:0.36:0.36:48.28: 19.01:28.2:0.76) | Antibacterial | [ | |
|
| EPS-0C, | Culture centrifugal extraction, ultra-filtration and High-Pressure Homogenizer | Xyl, Gal, Glc, Fuc, Ara, GlcA | 1.4 × 106 | Antibacterial, | [ |
|
| EPS | Culture centrifugal extraction and purification by | Xyl, Gal, GlcA, Rha, Glc, Ara | 1.5 × 106 | [ | |
| Cyanoflan | Cold aqueous extraction | Man, Glc, uronic acid, Gal, Xyl, Rha, Fuc, Ara (20:20:18:10:9:9:8:6) | >1 × 106 | [ | ||
|
| EPS | Culture centrifugal | GalA, Rib, Rha, Ara, Gal, Glc, Xyl | 2.25 × 105 | Antioxidant | [ |
|
| EPS | Culture centrifugal | Xyl, Glc | Antioxidant | [ | |
| EPS | Culture centrifugal extraction and purification by DEAE column | Uronic acid, Rha, Fuc, Ara, Xyl, Man, Gal, Glc | 2.37 × 105 | Antitussive, Immunomodulatory activity | [ | |
|
| EPS | Cold aqueous extractionand purification by dialysis | Ara, Rib, Man, GalA, Gal, Glc, GlcA (5.23:0.83:6.64:0.1:25.27:35.46:21.47) | Antioxidant, Anticancer | [ | |
| EPS | Culture centrifugal | Man, Ara, Glc, Rha, uronic acid (35:24:15:2:8) | Antioxidant | [ |
Figure 1Structures of several EPS, isolated from marine fungi in the last decade [74,83,84,85,86,87,88]. (a) EPS from Penicillium solitum; (b) EPS from Aspergillus versicolor; (c) EPS from Fusarium oxysporum; (d) EPS from Alternaria sp.; (e) EPS from Hansfordia sinuosae; (f) EPS from Aureobasidium melanogenum.
Figure 2Main biological activities of EPS from marine microorganisms.
Figure 3Potential mechanisms of ferroptosis-related immunomodulatory of AUM-1 [74].